According to The Insight Partners, The Microbiome Drugs market was valued at US$ 5 billion in 2025 and is expected to reach US$ 10.4 billion by 2034; it is estimated to record a CAGR of 8.48% during 2026-2034. The growing focus on personalized medicine and rising demand for advanced therapeutics are expected to drive market expansion significantly during the forecast period. The microbiome...